Show
Sort by
-
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE) : an open-label extension study
-
Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN) : a double-blind, randomised, phase 3A trial
-
- Journal Article
- A1
- open access
Dupilumab efficacy in patients with uncontrolled, moderate-to-severe allergic asthma
-
- Journal Article
- A1
- open access
Dupilumab efficacy in uncontrolled, moderate-to-severe asthma with self-reported chronic rhinosinusitis
-
- Journal Article
- A1
- open access
Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
-
- Journal Article
- A1
- open access
The significance of eosinophilic inflammation in chronic obstructive pulmonary disease
-
Blood eosinophil levels as a biomarker in COPD
-
- Journal Article
- A1
- open access
Association between blood eosinophil count and risk of readmission for patients with asthma : historical cohort study
-
After asthma : redefining airways diseases
-
Treatable traits : toward precision medicine of chronic airway diseases